Author

Suzanne Cory

The University of MelbourneORCID 0000-0002-6818-3451Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 2 Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:differential expression· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Hai Vu NguyeniD· 2 shared Andreas StrasseriD· 1 shared Andrew Tucker KuykendalliD· 1 shared Chia‐Ho ChengiD· 1 shared Dae Hyun LeeiD· 1 shared Daesung LeeiD· 1 shared Daniel J. MurphyiD· 1 shared Elizabeth M. HyjekiD· 1 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Hai Vu NguyenORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintMay 1, 2026

MNT loss in MYC-driven B lymphoma cells enhances apoptosis, inhibits proliferation and increases sensitivity to cancer drugs.

Hai Vu Nguyen, Marcel Michla, Feng Yan…·Suzanne Cory

This study shows that losing MNT in MYC-driven lymphoma cells increases apoptosis, reduces proliferation, and makes them more sensitive to cancer drugs.

DOI 10.64898/2026.04.29.721758

mousebulk RNA-seq

𝕏 PostBluesky

Cancer BiologyBlood Cancer DiscoveryPeer-reviewedMay 7, 2024

A Novel Subtype of Myeloproliferative Neoplasms Driven by a MYC-Alarmin Axis

Nicole D. Vincelette, Xiaoqing Yu, Andrew Tucker Kuykendall…·Seongseok Yun

This study identifies a MYC-S100A9 axis driving triple negative myelofibrosis and shows it is a therapeutic target.

11 citations

humanexperimental assay

𝕏 PostBluesky